Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 08:45 am Sale | 2024-12-31 | 13G | Editas Medicine, Inc. EDIT | Deep Track Capital LP | 0 0.000% | -5,473,086 (Position Closed) | Filing History |
| 2025-02-14 08:44 am Sale | 2024-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | Deep Track Capital LP | 3,460,756 4.650% | -602,920 (-14.84%) | Filing History |
| 2025-02-14 08:43 am Sale | 2024-12-31 | 13G | Nektar Therapeutics NKTR | Deep Track Capital LP | 131,733 1.070% | -929,777 (-87.59%) | Filing History |
| 2025-02-14 08:42 am Purchase | 2024-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital LP | 3,000,000 4.240% | 2,170 (+0.07%) | Filing History |
| 2025-02-14 08:41 am Sale | 2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Deep Track Capital LP | 0 0.000% | -699,281 (Position Closed) | Filing History |
| 2025-02-14 08:41 am Sale | 2024-12-31 | 13G | Bicycle Therapeutics plc BCYC | Deep Track Capital LP | 3,330,236 6.710% | -160,270 (-4.59%) | Filing History |
| 2025-02-14 08:40 am Sale | 2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital LP | 609,900 1.320% | -3,486,552 (-85.11%) | Filing History |
| 2025-02-10 4:04 pm Purchase | 2025-02-03 | 13G | Tectonic Therapeutic, Inc. TECX | Deep Track Capital LP | 1,401,938 7.600% | 1,401,938 (New Position) | Filing History |
| 2025-02-07 4:30 pm Purchase | 2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE | Deep Track Capital LP | 3,023,484 6.910% | 3,023,484 (New Position) | Filing History |
| 2025-01-17 4:02 pm Purchase | 2025-01-10 | 13G | COMPASS Pathways plc CMPS | Deep Track Capital LP | 9,274,589 9.990% | 9,274,589 (New Position) | Filing History |
| 2025-01-13 4:08 pm Purchase | 2025-01-06 | 13G | Structure Therapeutics Inc. GPCR | Deep Track Capital LP | 9,000,000 5.240% | 8,100,000 (+900.00%) | Filing History |
| 2024-12-23 4:42 pm Purchase | 2024-12-23 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital LP | 1,764,500 9.870% | 1,764,500 (New Position) | Filing History |
| 2024-12-23 4:41 pm Purchase | 2024-12-19 | 13G | 89bio, Inc. ETNB | Deep Track Capital LP | 6,477,949 5.410% | 4,477,949 (+223.90%) | Filing History |
| 2024-11-22 4:16 pm Sale | 2024-11-20 | 13G | Apellis Pharmaceuticals, Inc. APLS | Deep Track Capital LP | 6,000,000 4.820% | -220,265 (-3.54%) | Filing History |
| 2024-11-22 08:47 am Purchase | 2024-11-15 | 13G | Apellis Pharmaceuticals, Inc. APLS | Deep Track Capital LP | 6,220,265 5.000% | 6,220,265 (New Position) | Filing History |
| 2024-11-14 10:19 am Sale | 2024-09-30 | 13G | Ambrx Biopharma Inc. AMAM | Deep Track Capital LP | 0 0.000% | -3,710,412 (Position Closed) | Filing History |
| 2024-11-14 10:18 am Sale | 2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE | Deep Track Capital LP | 1,000,000 2.220% | -1,323,456 (-56.96%) | Filing History |
| 2024-11-14 10:00 am Sale | 2024-09-30 | 13G | Vigil Neuroscience, Inc. VIGL | Deep Track Capital LP | 1,553,996 3.920% | -2,095,730 (-57.42%) | Filing History |
| 2024-11-14 09:47 am Sale | 2024-09-30 | 13G | Verona Pharma plc VRNA | Deep Track Capital LP | 25,440,200 3.910% | -7,492,192 (-22.75%) | Filing History |
| 2024-11-14 09:46 am Sale | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital LP | 531,857 0.700% | -6,990,424 (-92.93%) | Filing History |